Company intelligence / Profile preview

YES Sinergy

Ownership: Private
Employees: ~300
Development stage: Other

Overview

Yes Sinergy developed a portfolio of innovative, natural, antibiotic-free feed additives based on sugar-cane yeast and organic chelated materials. Their solutions target mycotoxin mitigation, digestive health, pathogen control, and immune support across multiple species. The company was acquired by Olmix Group in July 2023 to expand both companies' reach globally.

Therapeutic areas: GastroenterologyImmunologyInfectious Diseases
Modalities: Small moleculeProtein
Industry: Veterinary

Partnerships

Close collaborations with Brazilian universities and world-class researchers during R&D phase.Now part of Olmix's global network post-acquisition.

Beyond the preview

Go deeper on YES Sinergy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on YES Sinergy.

Explore the full profile